François-Xavier Claret
- Molecular Biology top 2%
- Melanoma and MAPK Pathways 4
- Cell death mechanisms and regulation 4
- PI3K/AKT/mTOR signaling in cancer 3
- Protein Kinase Regulation and GTPase Signaling 3
- Cancer Research top 2%
- NF-κB Signaling Pathways 3
- Cell Biology top 2%
- Oncology top 5%
- Cancer-related Molecular Pathways 7
- Immunology and Allergy top 5%
-
- Estrogen and related hormone effects 3
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Audrey MindenAnning LinMichael KarinArie AboGary L. JohnsonCarol A. LangeFrank MercurioHoracio Martinetto
- Journals
- Molecular and Cellular Biology (3 papers)JNCI Journal of the National Cancer Institute (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
François-Xavier Claret
20 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 3.2k
- Cancer Research 687
- Cell Biology 606
- Oncology 964
- Immunology and Allergy 202
Countries citing papers authored by François-Xavier Claret
This map shows the geographic impact of François-Xavier Claret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François-Xavier Claret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François-Xavier Claret more than expected).
Fields of papers citing papers by François-Xavier Claret
This network shows the impact of papers produced by François-Xavier Claret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François-Xavier Claret. The network helps show where François-Xavier Claret may publish in the future.
Co-authorship network
The 25 scholars most cited alongside François-Xavier Claret, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 42 | |
| 2 | 2016 | 55 | |
| 3 | 2011 | 12 | |
| 4 | 2011 | 23 | |
| 5 | 2009 | 21 | |
| 6 | 2009 | 46 | |
| 7 | 2006 | 167 | |
| 8 | 2005 | 58 | |
| 9 | 2004 | 86 | |
| 10 | 2003 | 123 | |
| 11 | Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). | 2003 | 104 |
| 12 | 2002 | 92 | |
| 13 | 1999 | 422 | |
| 14 | 1998 | 310 | |
| 15 | 1996 | 402 | |
| 16 | 1996 | 16 | |
| 17 | Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hsbreakdown → | 1995 | 1366 |
| 18 | Identification of a Dual Specificity Kinase That Activates the Jun Kinases and p38-Mpk2breakdown → | 1995 | 706 |
| 19 | 1989 | 17 | |
| 20 | 1988 | 9 |
About François-Xavier Claret
François-Xavier Claret is a scholar working on Cancer Research, Toxicology and Oncology, having authored 20 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (7 papers), Melanoma and MAPK Pathways (4 papers), Cell death mechanisms and regulation (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Estrogen and related hormone effects (3 papers), NF-κB Signaling Pathways (3 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Molecular Biology (3.2k citations), Cancer Research (687 citations) and Cell Biology (606 citations). François-Xavier Claret has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Audrey Minden, Anning Lin, Michael Karin, Arie Abo, Michael Karin, Gary L. Johnson, Carol A. Lange, Frank Mercurio, Horacio Martinetto and Masahiko Hibi. Their work appears in journals such as Molecular and Cellular Biology, JNCI Journal of the National Cancer Institute, Clinical Cancer Research, Cell Death and Disease and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.